10X Genomics, Inc. (TXG)
71.55
+1.80
(+2.58%)
USD |
NASDAQ |
Oct 23, 16:00
71.60
+0.05
(+0.07%)
After-Hours: 20:00
10X Genomics Price to Book Value : 11.29 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 11.29 |
| October 22, 2026 | 11.01 |
| October 21, 2026 | 11.93 |
| October 20, 2026 | 11.28 |
| October 19, 2026 | 11.03 |
| October 16, 2026 | 11.02 |
| October 15, 2026 | 11.42 |
| October 14, 2026 | 11.54 |
| October 13, 2026 | 11.33 |
| October 12, 2026 | 11.87 |
| October 09, 2026 | 12.73 |
| October 08, 2026 | 12.20 |
| October 07, 2026 | 12.01 |
| October 06, 2026 | 12.73 |
| October 05, 2026 | 15.42 |
| October 02, 2026 | 14.76 |
| October 01, 2026 | 14.01 |
| September 30, 2026 | 14.26 |
| September 29, 2026 | 14.21 |
| September 28, 2026 | 13.97 |
| September 25, 2026 | 13.53 |
| September 24, 2026 | 13.27 |
| September 23, 2026 | 11.93 |
| September 22, 2026 | 12.74 |
| September 21, 2026 | 12.48 |
| Date | Value |
|---|---|
| September 18, 2026 | 12.09 |
| September 17, 2026 | 12.15 |
| September 16, 2026 | 11.47 |
| September 15, 2026 | 11.74 |
| September 14, 2026 | 11.06 |
| September 11, 2026 | 10.82 |
| September 10, 2026 | 10.48 |
| September 09, 2026 | 10.62 |
| September 08, 2026 | 10.35 |
| September 04, 2026 | 9.887 |
| September 03, 2026 | 9.977 |
| September 02, 2026 | 9.729 |
| September 01, 2026 | 9.466 |
| August 31, 2026 | 9.856 |
| August 28, 2026 | 9.712 |
| August 27, 2026 | 10.23 |
| August 26, 2026 | 10.14 |
| August 25, 2026 | 10.21 |
| August 24, 2026 | 10.07 |
| August 21, 2026 | 10.28 |
| August 20, 2026 | 10.08 |
| August 19, 2026 | 9.814 |
| August 18, 2026 | 8.779 |
| August 17, 2026 | 9.152 |
| August 14, 2026 | 8.852 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 19.67 |
| Tempus AI, Inc. | 27.36 |
| Intellia Therapeutics, Inc. | 2.157 |
| Personalis, Inc. | 7.169 |
| Alamar Biosciences, Inc. (California) | 6.807 |
Price to Book Value Related Metrics
| PS Ratio | 14.81 |
| Price to Free Cash Flow | 75.25 |
| Price | 71.55 |
| Earnings Yield | -0.82% |
| Market Cap | 9.322B |